Pfizer, Novartis agree UK price cuts for new breast cancer drugs Ruby Khatun Khatun17 Nov 2017 4:15 AM GMTLONDON: Pfizer and Novartis have agreed to price cuts for their rival breast cancer drugs Ibrance and Kisqali to ensure they can be used routinely...